Grants and Contracts Details
How DNA demethylation machinery can be targeted to specific genomic loci is still poorly understood, yet has important implications for tumor biology. Mounting evidence suggests that the microenvironment influences epigenetics; however, the mechanisms guiding these events have not been elucidated. We have demonstrated that integrin ?6?4 dramatically alters the transcriptome toward an invasive phenotype. The integrin regulates this process, in part, by substantially changing the epigenome through the regulation of DNA demethylation of select CpG rich regions and loci. Thus, we expect that understanding how integrin ?6?4 regulates the cancer epigenome holds the key to how site-specific and mechanotransduced epigenetics are regulated. Investigations into how integrin ?6?4 regulates DNA demethylation (funded by an NCI R21) led to our discovery that integrin ?6?4 utilizes and stimulates the base excision repair (BER) pathway to mediate these epigenetic events, but not in cells in which the link between integrin ?6?4 and the nucleus is compromised. We have also identified specific mutations in integrin ?4 subunit that preventing the integrin from binding to intermediate filaments and anchoring under the nucleus, thus indicating a pathway for integrin- mediated alterations in nuclear function. Based on our preliminary data and supporting literature, we hypothesize that integrin ?6?4 coordinates signal and mechano-transduction to the nucleus that drives BER and results in DNA demethylation of select loci, which in turn enhances tumor invasion and metastasis. We will test our central hypothesis through completion of the following three aims: 1) Define how integrin ?6?4 cytoskeletal linkages impacts invasion, metastasis and epigenetics, 2) Elucidate how integrin ?6?4 regulates BER-mediated DNA demethylation, and 3) Define changes in the epigenome mediated by integrin ?6?4 signaling. We expect that by defining the genes and pathways used by integrin ?6?4 to modulate the demethylation of select genes, we will significantly contribute to our understanding of how genomic loci are specifically targeted and the impact this signaling has on tumor invasion and metastasis.
|Effective start/end date||1/1/19 → 12/31/24|
- National Cancer Institute: $2,311,623.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.